Magdalena Jarosz-Biej

Gliwice Branch, Wybrzeże Armii Krajowej Street 15
Gliwice, SL 44102, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

TLR7 Agonist Imiquimod Improves the Therapeutic Antitumor Effect of High-Dose-Rate Brachytherapy.

TLR7 Agonist Imiquimod Improves the Therapeutic Antitumor Effect of High-Dose-Rate Brachytherapy.

Journal: Cancers

Published: February 02, 2026

Minimizing systemic toxicity of doxorubicin via targeted delivery of hypoxia-sensitive polymersomes.

Minimizing systemic toxicity of doxorubicin via targeted delivery of hypoxia-sensitive polymersomes.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: October 29, 2025

Targeting STING Signalling Polarizes Tumor-Associated Neutrophils to Boost Anticancer and Abscopal Antimetastatic Functions.

Targeting STING Signalling Polarizes Tumor-Associated Neutrophils to Boost Anticancer and Abscopal Antimetastatic Functions.

Journal: ImmunoTargets and therapy

Published: October 24, 2025

Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes Statuses.

Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes Statuses.

Journal: Cancers

Published: November 07, 2024

Combination of STING agonist with anti-vascular RGD-(KLAKLAK)2 peptide as a novel anti-tumor therapy.

Combination of STING agonist with anti-vascular RGD-(KLAKLAK)2 peptide as a novel anti-tumor therapy.

Journal: Cancer immunology, immunotherapy : CII

Published: April 05, 2024

Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context.

Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context.

Journal: Frontiers in oncology

Published: June 28, 2023

The comparison of adipose-derived stromal cells (ADSCs) delivery method in a murine model of hindlimb ischemia.

The comparison of adipose-derived stromal cells (ADSCs) delivery method in a murine model of hindlimb ischemia.

Journal: Stem cell research & therapy

Published: October 03, 2022

The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent-DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors.

The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent-DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors.

Journal: Cancers

Published: June 28, 2021

Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma.

Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma.

Journal: Scientific reports

Published: November 27, 2020

Vascular disrupting agents in cancer therapy.

Vascular disrupting agents in cancer therapy.

Journal: European journal of pharmacology

Published: June 20, 2020

Brachytherapy in a Single Dose of 10Gy as an "in situ" Vaccination.

Brachytherapy in a Single Dose of 10Gy as an "in situ" Vaccination.

Journal: International journal of molecular sciences

Published: June 02, 2020

Adipose tissue-derived stromal cells stimulated macrophages-endothelial cells interactions promote effective ischemic muscle neovascularization.

Adipose tissue-derived stromal cells stimulated macrophages-endothelial cells interactions promote effective ischemic muscle neovascularization.

Journal: European journal of pharmacology

Published: May 14, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026